SynthesisJAMA network open2025

Enfortumab Vedotin With or Without Pembrolizumab in Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis.

Shugo Yajima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.